194 related articles for article (PubMed ID: 28651346)
1. Effect of APOE ε Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis.
Kritharides L; Nordestgaard BG; Tybjærg-Hansen A; Kamstrup PR; Afzal S
J Clin Endocrinol Metab; 2017 Sep; 102(9):3390-3399. PubMed ID: 28651346
[TBL] [Abstract][Full Text] [Related]
2. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
[TBL] [Abstract][Full Text] [Related]
3. PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
Langsted A; Nordestgaard BG; Benn M; Tybjærg-Hansen A; Kamstrup PR
J Clin Endocrinol Metab; 2016 Sep; 101(9):3281-7. PubMed ID: 27218270
[TBL] [Abstract][Full Text] [Related]
4. Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population.
Kamstrup PR; Nordestgaard BG
JACC Heart Fail; 2016 Jan; 4(1):78-87. PubMed ID: 26656145
[TBL] [Abstract][Full Text] [Related]
5. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein.
Thomas PE; Vedel-Krogh S; Kamstrup PR; Nordestgaard BG
Eur Heart J; 2023 Apr; 44(16):1449-1460. PubMed ID: 36805188
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population.
Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
Atherosclerosis; 2016 Mar; 246():63-70. PubMed ID: 26761769
[TBL] [Abstract][Full Text] [Related]
8. Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction.
Baum L; Ng HK; Wong KS; Tomlinson B; Rainer TH; Chen X; Cheung WS; Tang J; Tam WW; Goggins W; Tong CS; Chan DK; Thomas GN; Chook P; Woo KS
Clin Chem Lab Med; 2006; 44(3):274-81. PubMed ID: 16519597
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease.
Kaltoft M; Langsted A; Afzal S; Kamstrup PR; Nordestgaard BG
J Am Coll Cardiol; 2022 Feb; 79(6):545-558. PubMed ID: 35144746
[TBL] [Abstract][Full Text] [Related]
10. Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction.
Ranjith N; Pegoraro RJ; Rom L; Rajput MC; Naidoo DP
Cardiovasc J S Afr; 2004; 15(3):111-7. PubMed ID: 15258620
[TBL] [Abstract][Full Text] [Related]
11. Association of apolipoprotein E genotypes with lipid levels and coronary risk.
Bennet AM; Di Angelantonio E; Ye Z; Wensley F; Dahlin A; Ahlbom A; Keavney B; Collins R; Wiman B; de Faire U; Danesh J
JAMA; 2007 Sep; 298(11):1300-11. PubMed ID: 17878422
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
[TBL] [Abstract][Full Text] [Related]
14. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of apolipoprotein E and risk of dementia in the general population.
Rasmussen KL; Tybjaerg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
Ann Neurol; 2015 Feb; 77(2):301-11. PubMed ID: 25469919
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.
Vongpromek R; Bos S; Ten Kate GJ; Yahya R; Verhoeven AJ; de Feyter PJ; Kronenberg F; Roeters van Lennep JE; Sijbrands EJ; Mulder MT
J Intern Med; 2015 Aug; 278(2):166-73. PubMed ID: 25487646
[TBL] [Abstract][Full Text] [Related]
17. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort.
Arsenault BJ; Boekholdt SM; Dubé MP; Rhéaume E; Wareham NJ; Khaw KT; Sandhu MS; Tardif JC
Circ Cardiovasc Genet; 2014 Jun; 7(3):304-10. PubMed ID: 24704946
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M
Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409
[TBL] [Abstract][Full Text] [Related]
20. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
